Oncorus, Inc.
ONCR · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.03 | -0.02 | -0.29 |
| FCF Yield | -1,242.98% | -44.50% | -19.26% | -14.09% |
| EV / EBITDA | -0.65 | -1.35 | -2.93 | -5.14 |
| Quality | ||||
| ROIC | -60.04% | -35.52% | -20.30% | -66.79% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.80 | 0.77 | 0.76 | 0.89 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | -100.00% |
| Free Cash Flow Growth | -37.47% | -56.81% | -34.36% | -61.46% |
| Safety | ||||
| Net Debt / EBITDA | -0.57 | 0.77 | 2.36 | 1.50 |
| Interest Coverage | -38.15 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |